Cravath, Swaine & Moore

Joshua Kameel

Deals
2
Latest
Sep 2026

Firm

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Joshua Kameel was named on, most recent first
Sep 2026 Royalty participation rights in U.S. net sales of tavapadon Bain CapitalDRI Healthcare TrustAsset saleLegal adviser to DRI Healthcare Trust (acquirer)Announced316.0Specialty finance and leasing+2DRI Healthcare Trust acquisition of Royalty participation rights in U.S. net sales of tavapadon
Apr 2026 Thermo Fisher Scientific's microbiology division Thermo Fisher ScientificAstorgAsset saleLegal adviser to Thermo Fisher (target)Announced1,075.0Diagnostics+1Astorg acquisition of Thermo Fisher Scientific's microbiology division

Deals where Joshua Kameel is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.